| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.004 |